E-LIB Suche - Ergebnisse für: Gottlieb, Alice

1

Effect of High-Dose Subcutaneous Spesolimab on Skin Manifes..:

Strober, Bruce ; Augustin, Matthias ; Tada, Yayoi...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 2 - p. s371 , 2024

Link: https://doi.org/10.25251..

2

Bimekizumab Efficacy through Year 1 in Patients with Modera..:

Han, George ; Gottlieb, Alice ; Armstrong, April...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 2 - p. s369 , 2024

Link: https://doi.org/10.25251..

3

Achievement of the National Psoriasis Foundation Treatment ..:

Gottlieb, Alice ; Burge, Russel ; Malatestinic, William...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 3 - p. s201 , 2023

Link: https://doi.org/10.25251..

4

42276 Long-Term Safety of Ixekizumab Treatment in Adult Pat..:

Lebwohl, Mark ; Deodhar, Atul ; Schwartzman, Sergio...
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB191 , 2023

Link: https://doi.org/10.1016/..

5

Real-world effectiveness of ixekizumab in mild, moderate, a..:

Gottlieb, Alice ; Burge, Russel ; Malatestinic, William...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 3 - p. s202 , 2023

Link: https://doi.org/10.25251..

6

Secukinumab in Moderate to Severe Hidradenitis Suppurativa:..:

Kimball, Alexa B ; Alavi, Afsaneh ; Jemec, Gregor BE...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 2 - p. s129 , 2023

Link: https://doi.org/10.25251..

7

Global consensus on the clinical course, treatment and mana..:

Puig, Lluis ; Choon, Siew Eng ; Gottlieb, Alice...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 2 - p. s122 , 2023

Link: https://doi.org/10.25251..

8

A US Claims Database Analysis Estimating Risk of All-Cause ..:

Gottlieb, Alice ; Zimmermann, Thomas ; Lavasani, Layla..
SKIN The Journal of Cutaneous Medicine. 7 (2023) 6 - p. s230 , 2023

Link: https://doi.org/10.25251..

9

43015 Ixekizumab real-world effectiveness at 24 weeks in pa..:

Gottlieb, Alice ; Burge, Russel ; Malatestinic, William...
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB185 , 2023

Link: https://doi.org/10.1016/..

10

42640 Efficacy and safety of secukinumab in patients with m..:

Kimball, Alexa B. ; Jemec, Gregor B.E. ; Alavi, Afsaneh...
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB156 , 2023

Link: https://doi.org/10.1016/..

11

Switching Between Adalimumab Reference Product and BI 69550..:

Menter, Alan ; Cohen, Stanley ; Kay, Jonathan...
American Journal of Clinical Dermatology. 23 (2022) 5 - p. 719-728 , 2022

Link: https://doi.org/10.1007/..

12

Deucravacitinib, an oral, selective tyrosine kinase 2 inhib..:

Lambert, Jo ; Paul, Carle ; Gottlieb, Alice.
SKIN The Journal of Cutaneous Medicine. 6 (2022) 6 - p. s45 , 2022

Link: https://doi.org/10.25251..

13

33884 Complete skin clearance for patients with moderate to..:

Blauvelt, Andrew ; Lebwohl, Mark ; Gottlieb, Alice...
Journal of the American Academy of Dermatology. 87 (2022) 3 - p. AB152 , 2022

Link: https://doi.org/10.1016/..

14

25799 Efficacy and safety of ixekizumab in patients with mo..:

Gottlieb, Alice ; de Vlam, Kurt ; Wang, Yan...
Journal of the American Academy of Dermatology. 85 (2021) 3 - p. AB70 , 2021

Link: https://doi.org/10.1016/..

15

25792 Improvements in BSA associate with improvements in it..:

Gottlieb, Alice ; Gooderham, Melinda ; Konicek, Bruce...
Journal of the American Academy of Dermatology. 85 (2021) 3 - p. AB70 , 2021

Link: https://doi.org/10.1016/..